• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Expression of angiogenic mediators in a patient with a retinal artery occlusion.

作者信息

Babapoor-Farrokhran Savalan, Poon David, Solomon Sharon, Montaner Silvia, Sodhi Akrit

机构信息

Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Department of Oncology and Diagnostic Sciences, School of Dentistry, Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland; Department of Pathology, School of Medicine, Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland.

出版信息

Can J Ophthalmol. 2017 Aug;52(4):e122-e125. doi: 10.1016/j.jcjo.2017.01.010. Epub 2017 Mar 23.

DOI:10.1016/j.jcjo.2017.01.010
PMID:28774531
Abstract
摘要

相似文献

1
Expression of angiogenic mediators in a patient with a retinal artery occlusion.视网膜动脉阻塞患者血管生成介质的表达
Can J Ophthalmol. 2017 Aug;52(4):e122-e125. doi: 10.1016/j.jcjo.2017.01.010. Epub 2017 Mar 23.
2
A rare case having hemi-retinal artery occlusion in one eye and hemi-retinal vein occlusion in the other: Diverse manifestations of retinal vascular occlusion.1例罕见的一眼发生半侧视网膜动脉阻塞而另一眼发生半侧视网膜静脉阻塞的病例：视网膜血管阻塞的多样表现
Indian J Ophthalmol. 2019 Feb;67(2):273-274. doi: 10.4103/ijo.IJO_987_18.
3
Cytokine Kinetics after Monthly Intravitreal Bevacizumab for Retinal Vein Occlusion Associated with Macular Oedema.每月玻璃体腔内注射贝伐单抗治疗黄斑水肿相关性视网膜静脉阻塞后的细胞因子动力学
Ophthalmic Res. 2016;56(4):207-214. doi: 10.1159/000445211. Epub 2016 May 4.
4
Efficacy of intravitreal bevacizumab for macular edema following branch retinal vein occlusion stratified by baseline visual acuity.玻璃体内注射贝伐单抗治疗视网膜分支静脉阻塞后黄斑水肿的疗效，按基线视力分层分析
Graefes Arch Clin Exp Ophthalmol. 2017 Apr;255(4):691-697. doi: 10.1007/s00417-016-3535-3. Epub 2016 Oct 29.
5
EFFICACY AND FREQUENCY OF INTRAVITREAL AFLIBERCEPT VERSUS BEVACIZUMAB FOR MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION.阿柏西普与雷珠单抗治疗视网膜中央静脉阻塞继发黄斑水肿的疗效及频率。
Retina. 2018 Sep;38(9):1795-1800. doi: 10.1097/IAE.0000000000001782.
6
QUALITATIVE AND QUANTITATIVE FOLLOW-UP USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF RETINAL VEIN OCCLUSION TREATED WITH ANTI-VEGF: Optical Coherence Tomography Angiography Follow-up of Retinal Vein Occlusion.使用抗血管内皮生长因子治疗的视网膜静脉阻塞的光学相干断层扫描血管造影的定性和定量随访：视网膜静脉阻塞的光学相干断层扫描血管造影随访
Retina. 2017 Jun;37(6):1176-1184. doi: 10.1097/IAE.0000000000001334.
7
Bevacizumab versus bevacizumab and macular grid photocoagulation for macular edema in eyes with non-ischemic branch retinal vein occlusion: results from a prospective randomized study.贝伐单抗对比贝伐单抗联合黄斑格栅光凝治疗非缺血性视网膜分支静脉阻塞性黄斑水肿：一项前瞻性随机研究的结果
Graefes Arch Clin Exp Ophthalmol. 2019 May;257(5):913-920. doi: 10.1007/s00417-018-04223-9. Epub 2019 Jan 4.
8
Intravitreal bevacizumab for parafoveal telangiectasia-associated choroidal neovascular membrane.玻璃体内注射贝伐单抗治疗黄斑旁毛细血管扩张相关脉络膜新生血管膜。
Indian J Ophthalmol. 2007 Nov-Dec;55(6):490-1. doi: 10.4103/0301-4738.36503.
9
Vitreous Fibronectin and Fibrinogen Expression Increased in Eyes With Proliferative Diabetic Retinopathy After Intravitreal Anti-VEGF Therapy.玻璃体内抗血管内皮生长因子（VEGF）治疗后，增殖性糖尿病视网膜病变患者眼内玻璃体液中纤连蛋白和纤维蛋白原表达增加。
Invest Ophthalmol Vis Sci. 2017 Nov 1;58(13):5783-5791. doi: 10.1167/iovs.17-22345.
10
"Off-label" use of intravitreal bevacizumab in non-ischemic macular edema secondary to retinal vein obstructions.玻璃体内注射贝伐单抗在视网膜静脉阻塞继发的非缺血性黄斑水肿中的“超说明书”使用。
Rom J Ophthalmol. 2016 Apr-Jun;60(2):90-95.

引用本文的文献

1
Imaging Hypoxia to Predict Primary Neuronal Cell Damage in Branch Retinal Artery Occlusion.利用影像学方法预测分支视网膜动脉阻塞中初始神经元细胞损伤。
Microcirculation. 2024 Oct;31(7):e12883. doi: 10.1111/micc.12883. Epub 2024 Aug 30.
2
Angiopoietin-like 4 is upregulated by amphiregulin and activates cell proliferation and migration through p38 kinase in head and neck squamous cell carcinoma.血管生成素样蛋白 4 受 Amphiregulin 上调，并通过 p38 激酶激活头颈部鳞状细胞癌中的细胞增殖和迁移。
J Oral Pathol Med. 2024 Jul;53(6):366-375. doi: 10.1111/jop.13545. Epub 2024 May 19.
3
Angiopoietin-like 4 induces head and neck squamous cell carcinoma cell migration through the NRP1/ABL1/PXN pathway.
血管生成素样蛋白 4 通过 NRP1/ABL1/PXN 通路诱导头颈部鳞状细胞癌细胞迁移。
Cell Signal. 2023 Aug;108:110697. doi: 10.1016/j.cellsig.2023.110697. Epub 2023 May 9.
4
Angiopoietin-like 4 binds neuropilins and cooperates with VEGF to induce diabetic macular edema.血管生成素样蛋白 4 结合神经纤毛蛋白并与 VEGF 协同诱导糖尿病性黄斑水肿。
J Clin Invest. 2019 Nov 1;129(11):4593-4608. doi: 10.1172/JCI120879.
5
A review of the multifunctionality of angiopoietin-like 4 in eye disease.血管生成素样蛋白 4 在眼部疾病中的多功能性研究综述。
Biosci Rep. 2018 Sep 13;38(5). doi: 10.1042/BSR20180557. Print 2018 Oct 31.